#ASNCJASN study: Can a urine biomarker identify AKI patients before they reach a tipping point? In ICU patients, higher urinary #CCL14 levels signaled a markedly greater risk of persistent severe AKI and kidney replacement therapy. kidney.pub/CJASN1212
November 2, 2026 at 4:30 PM
#ASNCJASN study: Can a urine biomarker identify AKI patients before they reach a tipping point? In ICU patients, higher urinary #CCL14 levels signaled a markedly greater risk of persistent severe AKI and kidney replacement therapy. kidney.pub/CJASN1212
The media needs trusted kidney experts. Thoughtful engagement by nephrologists can counter misinformation, amplify evidence-based care, raise CKD awareness, and help patients make more informed decisions, according to a #Perspective in #ASNCJASN. kidney.pub/CJASN1262
November 1, 2026 at 5:29 PM
The media needs trusted kidney experts. Thoughtful engagement by nephrologists can counter misinformation, amplify evidence-based care, raise CKD awareness, and help patients make more informed decisions, according to a #Perspective in #ASNCJASN. kidney.pub/CJASN1262
New CJASN podcast discusses validation of the Predicting Risk of Cardiovascular Disease EVENTs equations in CKD. Findings highlight the greatest clinical utility in earlier kidney disease, before risk becomes evident from eGFR and albuminuria alone. #ASNCJASN
kidney.pub/CPOD1030
kidney.pub/CPOD1030
November 2, 2026 at 7:51 PM
New CJASN podcast discusses validation of the Predicting Risk of Cardiovascular Disease EVENTs equations in CKD. Findings highlight the greatest clinical utility in earlier kidney disease, before risk becomes evident from eGFR and albuminuria alone. #ASNCJASN
kidney.pub/CPOD1030
kidney.pub/CPOD1030
#ASNCJASN: Only 24% of older adults with advanced CKD accurately perceived their kidney failure risk. Fatalism, caregiver burnout, and knowledge gaps remained key barriers, highlighting the need for better risk communication. kidney.pub/CJASN1220
October 30, 2026 at 4:32 PM
#ASNCJASN: Only 24% of older adults with advanced CKD accurately perceived their kidney failure risk. Fatalism, caregiver burnout, and knowledge gaps remained key barriers, highlighting the need for better risk communication. kidney.pub/CJASN1220
#ASNCJASN: A small, early eGFR dip may be a sign treatment is working. In MIRO-CKD, balcinrenone plus dapagliflozin produced modest, reversible eGFR reductions associated with greater lowering of blood pressure and albuminuria, with no increase in serious safety events. kidney.pub/CJASN1202
October 26, 2026 at 3:50 PM
#ASNCJASN: A small, early eGFR dip may be a sign treatment is working. In MIRO-CKD, balcinrenone plus dapagliflozin produced modest, reversible eGFR reductions associated with greater lowering of blood pressure and albuminuria, with no increase in serious safety events. kidney.pub/CJASN1202
A failing kidney allograft affects more than kidney function. Patients and providers share experiences of grief, fear, moral distress, and resilience in this #ASNCJASN #perspective, highlighting the need for better emotional support before, during, and after graft failure. kidney.pub/CJASN1250
October 28, 2026 at 4:29 PM
A failing kidney allograft affects more than kidney function. Patients and providers share experiences of grief, fear, moral distress, and resilience in this #ASNCJASN #perspective, highlighting the need for better emotional support before, during, and after graft failure. kidney.pub/CJASN1250
Resistant hypertension remains a major global challenge. Better BP monitoring, optimized multidrug therapy, and emerging precision treatments are improving how we diagnose and manage this high-risk condition. #Review in #ASNCJASN. kidney.pub/CJASN1266
October 25, 2026 at 5:30 PM
Resistant hypertension remains a major global challenge. Better BP monitoring, optimized multidrug therapy, and emerging precision treatments are improving how we diagnose and manage this high-risk condition. #Review in #ASNCJASN. kidney.pub/CJASN1266
How does obesity affect kidney health? This #review in #ASNCJASN explores the pathways linking obesity to CKD and summarizes evolving treatment approaches, including GLP-1 receptor agonists, incretin therapies, SGLT2 inhibitors, and bariatric surgery. kidney.pub/CJASN1233
October 22, 2026 at 4:30 PM
How does obesity affect kidney health? This #review in #ASNCJASN explores the pathways linking obesity to CKD and summarizes evolving treatment approaches, including GLP-1 receptor agonists, incretin therapies, SGLT2 inhibitors, and bariatric surgery. kidney.pub/CJASN1233
Discussing peer review, Devika Nair, MD, noted: “I view peer review as an opportunity to help my colleagues strengthen the validity, clarity, and impact of their work, after first highlighting their hard-won scientific contributions.” Top 5 #ASNCJASN reviewer 2026. #PRW2026
October 21, 2026 at 4:30 PM
New #researchletter in #ASNCJASN from HALT-PKD suggests that oral antibiotic exposure may be associated with a higher risk of kidney stones in ADPKD. Additional research is needed. kidney.pub/CJASN1211 @weddellite.bsky.social @cu-kidney.bsky.social
October 20, 2026 at 5:30 PM
New #researchletter in #ASNCJASN from HALT-PKD suggests that oral antibiotic exposure may be associated with a higher risk of kidney stones in ADPKD. Additional research is needed. kidney.pub/CJASN1211 @weddellite.bsky.social @cu-kidney.bsky.social
Could repeated cardiac injury during hemodialysis contribute to poor cardiovascular outcomes? #ASNCJASN review examines intradialytic myocardial stunning (IDMS), summarizes current evidence, and highlights priorities for future investigation. kidney.pub/CJASN1236
October 18, 2026 at 5:29 PM
Could repeated cardiac injury during hemodialysis contribute to poor cardiovascular outcomes? #ASNCJASN review examines intradialytic myocardial stunning (IDMS), summarizes current evidence, and highlights priorities for future investigation. kidney.pub/CJASN1236
Could plasma tacrolimus monitoring better detect tacrolimus-related kidney toxicity? In the ALLEGRO trial, higher plasma tacrolimus levels linked to lower eGFR and arteriolar hyalinosis, while whole blood levels were not. Larger studies needed to confirm findings. kidney.pub/CJASN1214 #ASNCJASN
October 14, 2026 at 5:59 PM
Could plasma tacrolimus monitoring better detect tacrolimus-related kidney toxicity? In the ALLEGRO trial, higher plasma tacrolimus levels linked to lower eGFR and arteriolar hyalinosis, while whole blood levels were not. Larger studies needed to confirm findings. kidney.pub/CJASN1214 #ASNCJASN
Thank you to Dr. Jonathan Zuckerman, a 2026 Top 5 #ASNCJASN reviewer, who shared: “Peer review is an important service to the nephrology and renal pathology community. Thoughtful review sharpens scientific interpretation and clinical relevance.” #PRW2026
@jzrenalpath.bsky.social
@jzrenalpath.bsky.social
October 14, 2026 at 3:03 PM
Thank you to Dr. Jonathan Zuckerman, a 2026 Top 5 #ASNCJASN reviewer, who shared: “Peer review is an important service to the nephrology and renal pathology community. Thoughtful review sharpens scientific interpretation and clinical relevance.” #PRW2026
@jzrenalpath.bsky.social
@jzrenalpath.bsky.social
A study in #ASNCJASN suggests dietary processing may matter for kidney health. Among 2,661 older adults, higher intake of ultra-processed foods, particularly animal-sourced UPFs, was associated with increased CKD risk. Further research is needed. kidney.pub/CJASN1207 @uwnephrology.bsky.social
October 11, 2026 at 3:53 PM
A study in #ASNCJASN suggests dietary processing may matter for kidney health. Among 2,661 older adults, higher intake of ultra-processed foods, particularly animal-sourced UPFs, was associated with increased CKD risk. Further research is needed. kidney.pub/CJASN1207 @uwnephrology.bsky.social
The microbiome is a promising player in CKD and hypertension, but clinical applications remain elusive. This perspective in #ASNCJASN highlights the evidence, gaps, and next steps toward microbiome-guided kidney care. kidney.pub/CJASN1234
October 10, 2026 at 3:40 PM
The microbiome is a promising player in CKD and hypertension, but clinical applications remain elusive. This perspective in #ASNCJASN highlights the evidence, gaps, and next steps toward microbiome-guided kidney care. kidney.pub/CJASN1234
The October issue of #ASNCJASN is now available online! Topics covered this month include:
- PD Outcomes in ADPKD
- Barriers to Re-Transplanation After Kidney Graft Loss
- and more
View the issue at kidney.pub/CJASN-1026
- PD Outcomes in ADPKD
- Barriers to Re-Transplanation After Kidney Graft Loss
- and more
View the issue at kidney.pub/CJASN-1026
October 9, 2026 at 8:21 PM
The October issue of #ASNCJASN is now available online! Topics covered this month include:
- PD Outcomes in ADPKD
- Barriers to Re-Transplanation After Kidney Graft Loss
- and more
View the issue at kidney.pub/CJASN-1026
- PD Outcomes in ADPKD
- Barriers to Re-Transplanation After Kidney Graft Loss
- and more
View the issue at kidney.pub/CJASN-1026
In >5,000 adults with CKD, adding urinary MCP-1, KIM-1, and EGF to traditional risk measures modestly improved prediction of kidney failure and disease progression, suggesting tubular injury biomarkers may refine risk stratification. #ASNCJASN. kidney.pub/CJASN1203
October 8, 2026 at 3:07 PM
In >5,000 adults with CKD, adding urinary MCP-1, KIM-1, and EGF to traditional risk measures modestly improved prediction of kidney failure and disease progression, suggesting tubular injury biomarkers may refine risk stratification. #ASNCJASN. kidney.pub/CJASN1203
A 2026 Top 5 #ASNCJASN reviewer, Dr. Ilia Beberashvili, shares: “The value of peer review lies not only in identifying limitations, but also in helping authors make their work clearer, stronger, and more clinically meaningful. It advances both science and patient care.” #PRW2026
October 7, 2026 at 5:59 PM
Cardio-kidney-metabolic (CKM) syndrome is a common and serious combination of obesity, diabetes, kidney disease, and heart disease. #ASNCJASN #review highlights how team-based care can improve access to effective treatments and lead to better patient outcomes. kidney.pub/CJASN1143
October 6, 2026 at 3:51 PM
Cardio-kidney-metabolic (CKM) syndrome is a common and serious combination of obesity, diabetes, kidney disease, and heart disease. #ASNCJASN #review highlights how team-based care can improve access to effective treatments and lead to better patient outcomes. kidney.pub/CJASN1143
What if the biggest cancer risk isn't a single drug, but the sum of every immunosuppressive exposure over a lifetime? This perspective in #ASNCJASN introduces "net immunosuppression" as a new way to think about cancer risk in glomerular disease. kidney.pub/CJASN1235 @kdjhaveri.bsky.social
October 4, 2026 at 3:53 PM
What if the biggest cancer risk isn't a single drug, but the sum of every immunosuppressive exposure over a lifetime? This perspective in #ASNCJASN introduces "net immunosuppression" as a new way to think about cancer risk in glomerular disease. kidney.pub/CJASN1235 @kdjhaveri.bsky.social
CKM syndrome is rising fastest where resources are scarcest. A new #ASNCJASN #perspective calls for community-based care, integrated digital health systems, and outcome-driven payment models to deliver scalable, equitable care, especially in low- and middle-income countries. kidney.pub/CJASN1222
October 1, 2026 at 3:07 PM
CKM syndrome is rising fastest where resources are scarcest. A new #ASNCJASN #perspective calls for community-based care, integrated digital health systems, and outcome-driven payment models to deliver scalable, equitable care, especially in low- and middle-income countries. kidney.pub/CJASN1222
Grateful to my institute PGIMER, Chandigarh and all my collaborators for our publication in 'the CJASN' on anemia in CKD 🙏🙏🙏
A ton of thanks to Indian Council of Medical Research (ICMR) for funding this project in #kidney #disease @asnpublications.bsky.social #ASNCJASN
#Nephsky #Nephbluesky
A ton of thanks to Indian Council of Medical Research (ICMR) for funding this project in #kidney #disease @asnpublications.bsky.social #ASNCJASN
#Nephsky #Nephbluesky
Managing iron-deficiency anemia is a challenge in CKD. This randomized trial in #ASNCJASN found that adding lactoferrin to oral iron improved hemoglobin and iron status more than iron alone, suggesting a potentially accessible treatment strategy. kidney.pub/CJASN11204 @divyaveerssneph.bsky.social
September 30, 2026 at 3:05 PM
Grateful to my institute PGIMER, Chandigarh and all my collaborators for our publication in 'the CJASN' on anemia in CKD 🙏🙏🙏
A ton of thanks to Indian Council of Medical Research (ICMR) for funding this project in #kidney #disease @asnpublications.bsky.social #ASNCJASN
#Nephsky #Nephbluesky
A ton of thanks to Indian Council of Medical Research (ICMR) for funding this project in #kidney #disease @asnpublications.bsky.social #ASNCJASN
#Nephsky #Nephbluesky
Managing iron-deficiency anemia is a challenge in CKD. This randomized trial in #ASNCJASN found that adding lactoferrin to oral iron improved hemoglobin and iron status more than iron alone, suggesting a potentially accessible treatment strategy. kidney.pub/CJASN11204 @divyaveerssneph.bsky.social
September 29, 2026 at 7:03 PM
Managing iron-deficiency anemia is a challenge in CKD. This randomized trial in #ASNCJASN found that adding lactoferrin to oral iron improved hemoglobin and iron status more than iron alone, suggesting a potentially accessible treatment strategy. kidney.pub/CJASN11204 @divyaveerssneph.bsky.social
Higher urine protein-to-creatinine ratio was strongly associated with faster CKD progression and earlier kidney failure in >2,700 adults with advanced CKD. These findings in #ASNCJASN highlight the value of a simple test for risk stratification in clinical practice. kidney.pub/CJASN1206
September 27, 2026 at 6:49 PM
Higher urine protein-to-creatinine ratio was strongly associated with faster CKD progression and earlier kidney failure in >2,700 adults with advanced CKD. These findings in #ASNCJASN highlight the value of a simple test for risk stratification in clinical practice. kidney.pub/CJASN1206